HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
Recruiting now · Not applicable
Conditions studied: Cirrhosis, End Stage Liver DIsease, Liver Cirrhosis, Liver Disease Chronic
In brief
This research study is evaluating a program that entails a healthcare at home intervention for people with advanced liver disease.
Key facts
- Study ID
- NCT05205954
- Run by
- Massachusetts General Hospital
- People needed
- 30
- Starts
- 2025-07-21
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-07-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients ≥ 18 years old with diagnosis of cirrhosis based on histology, radiology, and/or elastography presenting to the emergency department or inpatient general medicine service
- Patients must have one of the following:
- Ascites (requiring diuretics or serial large volume paracenteses)
- Hepatic hydrothorax (requiring diuretics)
- Hepatic encephalopathy (requiring medications)
- Exclusion Criteria: All existing MGB home hospital criteria apply, with the following taking precedent for this specific condition
- History of solid organ transplantation
- On hemodialysis
- MELD score > 20
- Score <10 on Simplified Animal Naming Test (S-ANT1)
- Current admission for hemodynamically significant GI bleeding or alcohol withdrawal
- Require routine administration of controlled substances
- Those deemed ineligible based on the MGH Home Hospital, inpatient medicine or hepatology clinician evaluation
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
- Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.